Literature DB >> 22108696

Follow-up of patients with resected thoracic malignancies.

Paul M Claiborne1, Clara S Fowler, Ara A Vaporciyan.   

Abstract

The authors have systematically performed a literature search using 8 databases identifying established guidelines for follow-up after resected thoracic malignancies. Seven different societies' (found to have published recommendations for non-small cell lung cancer, esophageal cancer, thymoma, or mesothelioma) guidelines are reviewed in this article. High-quality evidence leading to consistent, strong recommendations among societies has not been found. With the subsequent advancements in surgical treatment and other curative modalities, the ability to detect and intervene with curative therapy at earlier stages of disease in a growing portion of the current patient population will benefit from higher-quality evidence. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22108696     DOI: 10.1016/j.thorsurg.2011.08.011

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  2 in total

1.  Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.

Authors:  Ting Wang; Yiqian Liang; Asmitananda Thakur; Shuo Zhang; Tian Yang; Tianjun Chen; Lei Gao; Mingwei Chen; Hui Ren
Journal:  Tumour Biol       Date:  2015-09-11

2.  Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis.

Authors:  Elena Rodríguez-Camacho; Salvador Pita-Fernández; Sonia Pértega-Díaz; Beatriz López-Calviño; Teresa Seoane-Pillado
Journal:  J Epidemiol       Date:  2015-01-19       Impact factor: 3.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.